The 17 most recent market catalysts affecting $ACB, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 10, 2026
Corporate Catalyst
Bullish
Impact 85
TD Cowen Analyst Recommends Aurora Cannabis Shareholders Accept Organigram's Takeover Offer
TD Cowen analyst Derek Lessard has advised Aurora Cannabis shareholders to accept Organigram Global's $561 million acquisition offer, announced on November 3, 2026. This recommenda…
Nov 6, 2026
Corporate Catalyst
Bullish
Impact 75
Aurora Cannabis Reports Fiscal Q2 2027 Financial Results
Aurora Cannabis reported its Q2 2027 financial results, showing C$86.0 million in revenue and C$14.0 million in adjusted EBITDA. The key development, however, is the cancellation o…
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 92
Aurora Cannabis Reports Q2 Revenue of CA$86.0 Million
Aurora Cannabis announced Q2 2026 revenue of CA$86.0 million, substantially surpassing the FactSet consensus estimate of CA$71.4 million. This significant beat indicates stronger-t…
Nov 3, 2026
Corporate Catalyst
Bearish
Impact 75
Canadian Investment Regulatory Organization Imposes Trading Halt on Aurora Cannabis Inc.
On November 3, 2026, the Canadian Investment Regulatory Organization (CIRO) halted trading in Aurora Cannabis Inc. (TSX: ACB) shares, citing 'Pending News.' This regulatory action …
Oct 26, 2026
Corporate Catalyst
Bearish
Impact 75
Alberta Securities Commission Dismisses Curaleaf's Application Regarding Aurora Cannabis
The Alberta Securities Commission (ASC) dismissed Curaleaf's application challenging Aurora Cannabis's At-the-Market (ATM) program, confirming its compliance with securities laws. …
Oct 26, 2026
Corporate Catalyst
Bearish
Impact 60
Alberta Securities Commission Dismisses Curaleaf's Application Against Aurora Cannabis
The Alberta Securities Commission's dismissal of Curaleaf's application against Aurora Cannabis's ATM program is a win for Aurora, validating its financing mechanism. This decision…
Oct 14, 2026
Corporate Catalyst
Neutral
Impact 85
Aurora Cannabis' Board Recommends Shareholders Reject Offer By Curaleaf Holdings
Aurora Cannabis' Board of Directors has unanimously recommended that shareholders reject the hostile takeover offer from Curaleaf Holdings. This is a significant development in the…
Oct 8, 2026
Corporate Catalyst
Bullish
Impact 65
Aurora Cannabis Completes Major Expansion Of Its Facility In Leuna, Germany
Aurora Cannabis announced the completion of a significant expansion of its German facility, which will more than double its annual flower output and enhance its EU-GMP manufacturin…
Oct 6, 2026
Corporate Catalyst
Neutral
Impact 85
Aurora Cannabis Shareholders Urged For No Action Against Curaleaf's Hostile Acquisition Offer
This filing discloses that Aurora Cannabis is publicly responding to a revised hostile takeover bid from Curaleaf. Curaleaf has increased its offer to US$5.00 per share, consisting…
Sep 16, 2026
Corporate Catalyst
Bullish
Impact 55
Aurora Cannabis Re-Affirms FY27 Q2 Guidance For Sequential Growth In Quarterly Net Revenue And Adjusted EBITDA
Aurora Cannabis has reaffirmed its Q2 FY27 guidance for sequential growth in net revenue and adjusted EBITDA. This is significant because it signals management's confidence in thei…
Sep 14, 2026
Corporate Catalyst
Bearish
Impact 75
Aurora Cannabis Says Curaleaf Application To Halt Its ATM Program Is Attempt To Distract From Inadequate Hostile Bid, Says ATM Was Disclosed In February 2026 Before Offer; Board Reiterates Unanimous Recommendation To Reject Bid
This headline indicates a significant corporate catalyst in the cannabis sector, specifically a hostile takeover attempt. The 'distraction' accusation and the board's unanimous rej…
Sep 2, 2026
Corporate Catalyst
Bearish
Impact 92
Aurora Cannabis Fires Back at Curaleaf’s Hostile Takeover Bid
Aurora Cannabis (ACB) has formally rejected a hostile takeover bid from Curaleaf Holdings (CURLF), advising its shareholders to take no action. This is a significant corporate cata…
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 95
Aurora Cannabis Urged Shareholders To Reject A Merger Bid From Curaleaf, Warning That The Hostile Bid Would Put Aurora Shareholders' Value And Future Upside At Risk
Aurora Cannabis has filed a Directors' Circular, unanimously recommending shareholders reject Curaleaf's hostile takeover bid. Aurora argues the bid significantly undervalues the c…
Aug 11, 2026
Corporate Catalyst
Neutral
Impact 85
Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Below December 2025 Trading Levels
This is a significant corporate catalyst for the cannabis sector, indicating consolidation and potential valuation shifts. The unsolicited nature of Curaleaf's bid for Aurora Canna…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 95
Aurora Cannabis shares are trading higher after Curaleaf announced its intention to make an offer to purchase Aurora Cannabis for $4 per share.
This news represents a significant corporate catalyst for the cannabis sector. An acquisition of Aurora Cannabis by Curaleaf would consolidate market share and potentially lead to …
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 75
Aurora Cannabis Q1 EPS $(0.05) Beats $(0.13) Estimate, Sales $48.798M Miss $50.510M Estimate
Aurora Cannabis (ACB) reported its Q1 earnings, showing a mixed bag for investors. While the company managed to beat analyst estimates for earnings per share, reporting a loss of $…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 75
Aurora Cannabis Q1 EPS $(0.07) Beats $(0.18) Estimate, Sales $67.554M Beat $65.235M Estimate
Aurora Cannabis (ACB) announced Q1 results that surpassed analyst expectations for both EPS and sales. This matters because beating estimates, even with a net loss and year-over-ye…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.